General Information of Drug (ID: DMVBTHA)

Drug Name
HOMOPHENYLALANINYLMETHANE Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
46937105
TTD Drug ID
DMVBTHA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug(s) Targeting Cathepsin F (CTSF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27998201-Compound-12 DM8QZNC Bone cancer 2B5Z Patented [2]
PMID27998201-Compound-5 DMVZ0ND Chronic obstructive pulmonary disease CA22 Patented [2]
PMID22686657C(R)-26 DM19D7G Discovery agent N.A. Investigative [3]
WRR-99 DM8ZA6K Discovery agent N.A. Investigative [4]
Benzoyl-Arginine-Alanine-Methyl Ketone DMC7TNF Discovery agent N.A. Investigative [4]
WRR-112 DMP761U Discovery agent N.A. Investigative [4]
BENZOYL-TYROSINE-ALANINE-METHYL KETONE DMIRD8S Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cathepsin F (CTSF) TTJOKD1 CATF_HUMAN Inhibitor [1]

References

1 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
2 Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
3 Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F. J Med Chem. 2012 Jun 28;55(12):5982-6.
4 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.